|
1
|
Leffler H, Carlsson S, Hedlund M, Qian Y
and Poirier F: Introduction to galectins. Glycoconj J. 19:433–440.
2004. View Article : Google Scholar
|
|
2
|
Krześlak A and Lipińska A: Galectin-3 as a
multifunctional protein. Cell Mol Biol Lett. 9:305–328. 2004.
|
|
3
|
Liu FT and Rabinovich GA: Galectins as
modulators of tumour progression. Nat Rev Cancer. 5:29–41. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fukumori T, Kanayama HO and Raz A: The
role of galectin-3 in cancer drug resistance. Drug Resist Updat.
10:101–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song S, Ji B, Ramachandran V, Wang H,
Hafley M, Logsdon C and Bresalier RS: Overexpressed galectin-3 in
pancreatic cancer induces cell proliferation and invasion by
binding Ras and activating Ras signaling. PLoS One. 7:e426992012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim SJ, Choi IJ, Cheong TC, Lee SJ, Lotan
R, Park SH and Chun KH: Galectin-3 increases gastric cancer cell
motility by up-regulating fascin-1 expression. Gastroenterology.
138:1035–1045. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khaldoyanidi SK, Glinsky VV, Sikora L,
Glinskii AB, Mossine VV, Quinn TP, Glinsky GV and Sriramarao P:
MDA-MB-435 human breast carcinoma cell homo- and heterotypic
adhesion under flow conditions is mediated in part by
Thomsen-Friedenreich antigengalectin-3 interactions. J Biol Chem.
273:4127–4134. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang LP, Chen SW, Zhuang SM, Li H and Song
M: Galectin-3 accelerates the progression of oral tongue squamous
cell carcinoma via a Wnt/β-catenin-dependent pathway. Pathol Oncol
Res. 19:461–474. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shimura T, Takenaka Y, Tsutsumi S, Hogan
V, Kikuchi A and Raz A: Galectin-3, a novel binding partner of
β-catenin. Cancer Res. 64:6363–6367. 2004. View Article : Google Scholar
|
|
10
|
Morin PJ: Beta-catenin signaling and
cancer. Bioessays. 21:1021–1030. 1999. View Article : Google Scholar
|
|
11
|
MacDonald BT and He X: Frizzled and LRP5/6
receptors for Wnt/β-catenin signaling. Cold Spring Harb Perspect
Biol. 4:2012.pii: a007880. View Article : Google Scholar
|
|
12
|
Bodine PV: Wnt signaling control of bone
cell apoptosis. Cell Res. 18:248–253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gaur T, Lengner CJ, Hovhannisyan H, Bhat
RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS
and Lian JB: Canonical WNT signaling promotes osteogenesis by
directly stimulating Runx2 gene expression. J Biol Chem.
280:33132–33140. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Selvarajah GT, Kirpensteijn J, van
Wolferen ME, Rao NA, Fieten H and Mol JA: Gene expression profiling
of canine osteosarcoma reveals genes associated with short and long
survival times. Mol Cancer. 8:722009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lamoureux F, Trichet V, Chipoy C,
Blanchard F, Gouin F and Redini F: Recent advances in the
management of osteosarcoma and forthcoming therapeutic strategies.
Expert Rev Anticancer Ther. 7:169–181. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim J and Hwan Kim S: CK2 inhibitor
CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition
in A549 human lung adenocarcinoma cells. PLoS One. 8:e743422013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Santos A, Bakker AD, Zandieh-Doulabi B, de
Blieck-Hogervorst JM and Klein-Nulend J: Early activation of the
beta-catenin pathway in osteocytes is mediated by nitric oxide,
phosphatidyl inositol-3 kinase/Akt, and focal adhesion kinase.
Biochem Biophys Res Commun. 391:364–369. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haydon RC, Deyrup A, Ishikawa A, Heck R,
Jiang W, Zhou L, Feng T, King D, Cheng H, Breyer B, Peabody T,
Simon MA, Montag AG and He TC: Cytoplasmic and/or nuclear
accumulation of the beta-catenin protein is a frequent event in
human osteosarcoma. Int J Cancer. 102:338–342. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dieudonne FX, Marion A, Hay E, Marie PJ
and Modrowski D: High Wnt signaling represses the proapoptotic
proteoglycan syndecan-2 in osteosarcoma cells. Cancer Res.
70:5399–5408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye Q, Cai W, Zheng Y, Evers BM and She QB:
ERK and AKT signaling cooperate to translationally regulate
survivin expression for metastatic progression of colorectal
cancer. Oncogene. 33:1828–1839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hwang YP, Yun HJ, Choi JH, Han EH, Kim HG,
Song GY, Kwon KI, Jeong TC and Jeong HG: Suppression of EGF-induced
tumor cell migration and matrix metalloproteinase-9 expression by
capsaicin via the inhibition of EGFR-mediated FAK/Akt, PKC/Raf/ERK,
p38 MAPK, and AP-1 signaling. Mol Nutr Food Res. 55:594–605. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Henderson NC, Mackinnon AC, Farnworth SL,
Poirier F, Russo FP, Iredale JP, Haslett C, Simpson KJ and Sethi T:
Galectin-3 regulates myofibroblast activation and hepatic fibrosis.
Proc Natl Acad Sci USA. 103:5060–5065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nishi Y, Sano H, Kawashima T, Okada T,
Kuroda T, Kikkawa K, Kawashima S, Tanabe M, Goto T, Matsuzawa Y,
Matsumura R, Tomioka H, Liu FT and Shirai K: Role of galectin-3 in
human pulmonary fibrosis. Allergol Int. 56:57–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Filer A, Bik M, Parsonage GN, Fitton J,
Trebilcock E, Howlett K, Cook M, Raza K, Simmons DL, Thomas AM,
Salmon M, Scheel-Toellner D, Lord JM, Rabinovich GA and Buckley CD:
Galectin 3 induces a distinctive pattern of cytokine and chemokine
production in rheumatoid synovial fibroblasts via selective
signaling pathways. Arthritis Rheum. 60:1604–1614. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aubin JE, Gupta AK, Bhargava U and Turksen
K: Expression and regulation of galectin 3 in rat osteoblastic
cells. J Cell Physiol. 169:468–480. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Radosavljevic G, Volarevic V, Jovanovic I,
Milovanovic M, Pejnovic N, Arsenijevic N, Hsu DK and Lukic ML: The
roles of Galectin-3 in autoimmunity and tumor progression. Immunol
Res. 52:100–110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu KL, Huang EY, Jhu EW, Huang YH, Su WH,
Chuang PC and Yang KD: Overexpression of galectin-3 enhances
migration of colon cancer cells related to activation of the
K-Ras-Raf-Erk1/2 pathway. J Gastroenterol. 48:350–359. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu KH, Yang HW, Su CW, Lue KH, Yang SF and
Hsieh YS: Phyllanthus urinaria suppresses human osteosarcoma
cell invasion and migration by transcriptionally inhibiting u-PA
via ERK and Akt signaling pathways. Food Chem Toxicol. 52:193–199.
2013. View Article : Google Scholar
|
|
30
|
Bartholomeusz C and Gonzalez-Angulo AM:
Targeting the PI3K signaling pathway in cancer therapy. Expert Opin
Ther Targets. 16:121–130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ishizawar R and Parsons SJ: c-Src and
cooperating partners in human cancer. Cancer Cell. 6:209–214. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
McLean GW, Carragher NO, Avizienyte E,
Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase
in cancer - a new therapeutic opportunity. Nat Rev Cancer.
5:505–515. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Summy JM and Gallick GE: Src family
kinases in tumor progression and metastasis. Cancer Metastasis Rev.
22:337–358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cai H, Smith DA, Memarzadeh S, Lowell CA,
Cooper JA and Witte ON: Differential transformation capacity of Src
family kinases during the initiation of prostate cancer. Proc Natl
Acad Sci USA. 108:6579–6584. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi YL, Bocanegra M, Kwon MJ, Shin YK,
Nam SJ, Yang JH, Kao J, Godwin AK and Pollack JR: LYN is a mediator
of epithelial-mesenchymal transition and a target of dasatinib in
breast cancer. Cancer Res. 70:2296–2306. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guan H, Zhou Z, Gallick GE, Jia SF,
Morales J, Sood AK, Corey SJ and Kleinerman ES: Targeting Lyn
inhibits tumor growth and metastasis in Ewing’s sarcoma. Mol Cancer
Ther. 7:1807–1816. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Markowska AI, Liu FT and Panjwani N:
Galectin-3 is an important mediator of VEGF- and bFGF-mediated
angiogenic response. J Exp Med. 207:1981–1993. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shankar J, Wiseman SM, Meng F, Kasaian K,
Strugnell S, Mofid A, Gown A, Jones SJ and Nabi IR: Coordinated
expression of galectin-3 and caveolin-1 in thyroid cancer. J
Pathol. 228:56–66. 2012.PubMed/NCBI
|
|
39
|
Heijink IH, de Bruin HG and van den Berge
M: Role of aberrant WNT signalling in the airway epithelial
response to cigarette smoke in chronic obstructive pulmonary
disease. Thorax. 68:709–716. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kuniyasu H, Ellis LM, Evans DB, Abbruzzese
JL, Fenoglio CJ, Bucana CD, Cleary KR, Tahara E and Fidler IJ:
Relative expression of E-cadherin and type IV collagenase genes
predicts disease outcome in patients with resectable pancreatic
carcinoma. Clin Cancer Res. 5:25–33. 1999.PubMed/NCBI
|
|
41
|
Brabletz T, Jung A, Dag S, Reu S and
Kirchner T: Beta-catenin induces invasive growth by activating
matrix metalloproteinases in colorectal carcinoma. Verh Dtsch Ges
Pathol. 84:175–181. 2000.(In German).
|
|
42
|
Xin ZF, Kim YK and Jung ST: Risedronate
inhibits human osteosarcoma cell invasion. J Exp Clin Cancer Res.
28:1052009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Federman N, Bernthal N, Eilber FC and Tap
WD: The multi-disciplinary management of osteosarcoma. Curr Treat
Options Oncol. 10:82–93. 2009. View Article : Google Scholar
|
|
44
|
Zhang Y, Sun S, Chen J, Ren P, Hu Y, Cao
Z, Sun H and Ding Y: Oxymatrine induces mitochondria dependent
apoptosis in human osteosarcoma MNNG/HOS cells through inhibition
of PI3K/Akt pathway. Tumour Biol. 35:1619–1625. 2014. View Article : Google Scholar : PubMed/NCBI
|
